Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Does the clinical course of depression determine improvement in symptoms and quality of life?

Moses T, Leuchter AF, Cook I, Abrams M.

J Nerv Ment Dis. 2006 Apr;194(4):241-8.

PMID:
16614544
2.

[Antidepressants and their onset of action: a major clinical, methodological and pronostical issue].

Gourion D.

Encephale. 2008 Jan;34(1):73-81. doi: 10.1016/j.encep.2007.12.001. Epub 2008 Feb 5. Review. French.

PMID:
18514154
3.

Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.

Papakostas GI, Fava M.

Eur Neuropsychopharmacol. 2009 Jan;19(1):34-40. doi: 10.1016/j.euroneuro.2008.08.009. Epub 2008 Sep 26. Review.

PMID:
18823760
4.

Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.

Shelton RC, Prakash A, Mallinckrodt CH, Wohlreich MM, Raskin J, Robinson MJ, Detke MJ.

Int J Clin Pract. 2007 Aug;61(8):1337-48. Review.

PMID:
17627710
5.

Quality of life: the ultimate outcome measure of interventions in major depressive disorder.

IsHak WW, Greenberg JM, Balayan K, Kapitanski N, Jeffrey J, Fathy H, Fakhry H, Rapaport MH.

Harv Rev Psychiatry. 2011 Sep-Oct;19(5):229-39. doi: 10.3109/10673229.2011.614099. Review.

PMID:
21916825
6.
7.

[Psychological factors in psoriasis: review of literature].

SzumaƄski J, Kokoszka A.

Psychiatr Pol. 2001 Sep-Oct;35(5):831-8. Review. Polish.

PMID:
11842614
8.

Gene-environment interaction in major depression and antidepressant treatment response.

Keers R, Uher R.

Curr Psychiatry Rep. 2012 Apr;14(2):129-37. doi: 10.1007/s11920-011-0251-x. Review.

PMID:
22198824

Supplemental Content

Support Center